Morning Headlines 12/27/24

Digital health companies got pummeled by Wall Street in 2024 as industry adapts to post-Covid slowdown

A CNBC analysis of 39 publicly traded digital health companies finds that two-thirds lost value in 2024 ,with high-profile stumbles by Teladoc Health, Progyny, GoodRx, Dexcom, and 23andMe.  

Adoption of “hospital-at-home” programs remains concentrated among larger, urban, not-for-profit and academic hospitals

Researchers find that CMS’s four-year-old program that encourages a home alternative to hospital admission will need to offer different incentives to expand to smaller, rural, and non-teaching hospitals.

Providers Used Medicare Part D Eligibility Verification Transactions for Permissible Purposes

An HHS OIG investigation finds minimal improper use of Medicare Part D prescription eligibility transactions by providers after CMS tightened controls.

Avel eCare Announces the Acquisition of Hospital Pharmacy Management to Enhance Pharmacy Telemedicine Services

Telemedicine provider Avel ECare acquires Hospital Pharmacy Management, which offers remote pharmacy order verification and hospital pharmacy management.